EGFR and HER2 gene amplification in AAH and adenocarcinoma of the lung
| Gene | Adenocarcinoma | Total (n = 86) | |||
|---|---|---|---|---|---|
| AAH (n = 14) | BAC (n = 31) | Early MX (n = 22) | Overt MX (n = 33) | ||
| AAH, atypical adenomatous hyperplasia; BAC, bronchioloalveolar carcinoma; EGFR, epidermal growth factor receptor; MX, adenocarcinoma with mixed subtypes. | |||||
| EGFR | 0 | 0 | 2 | 2 | 4 (4.7%) |
| HER2 | 0 | 0 | 1 | 1 | 2 (2.3%) |